Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bicycle Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10866
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company’s proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to identify bicycles that provide antibody-like affinity and selectivity in a much smaller chemically synthesized molecule. It also exhibits cross-species activities that allow extrapolation from efficacy and toxicology experiments, among others. Bicycle Therapeutics operates with other biotechnology companies for the development of bicyclic peptide inhibitors for the treatment of ophthalmic diseases such as diabetic macular edema. The company works in collaboration with Cancer Research UK(CRUK), AstraZeneca Plc in the areas of oncology, respiratory, cardiovascular and metabolic diseases, among others. It has operations in Massachusetts, the US. Bicycle Therapeutics is headquartered in Cambridge, the UK.

Bicycle Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Bicycle Therapeutics Raises USD51.35 Million in Series B Round of Financing 10
Bicycle Therapeutics Raises USD32 Million in Series A Venture Financing 12
Bicycle Therapeutics Raises US$6 Million In Venture Financing 13
Partnerships 15
Bioverativ Enters into Research Agreement with Bicycle Therapeutics 15
Cancer Research UK Enters into Agreement with Bicycle Therapeutics 16
Bicycle Therapeutics Expands into Agreement with AstraZeneca 17
Licensing Agreements 18
ThromboGenics Expands Licensing Agreement with Bicycle Therapeutics 18
Bicycle Therapeutics Ltd – Key Competitors 19
Bicycle Therapeutics Ltd – Key Employees 20
Bicycle Therapeutics Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Nov 01, 2018: Bicycle Therapeutics strengthens leadership team with appointment of Phil Jeffrey, Ph.D., as SVP pre-clinical development 22
Sep 26, 2017: Bicycle Therapeutics Strengthens Senior Management Team With Appointment of Maria Koehler, M.D., Ph.D., as Chief Medical Officer 23
Aug 01, 2017: Bicycle Therapeutics Expands Leadership Team with Appointment of Lee Kalowski as Chief Financial Officer 24
Jan 05, 2017: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer 25
Government and Public Interest 26
Jan 04, 2018: Bicycle Therapeutics Secures an Innovate UK Grant to Develop the Next Generation of Antibiotics 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bicycle Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bicycle Therapeutics Raises USD51.35 Million in Series B Round of Financing 10
Bicycle Therapeutics Raises USD32 Million in Series A Venture Financing 12
Bicycle Therapeutics Raises US$6 Million In Venture Financing 13
Bioverativ Enters into Research Agreement with Bicycle Therapeutics 15
Cancer Research UK Enters into Agreement with Bicycle Therapeutics 16
Bicycle Therapeutics Expands into Agreement with AstraZeneca 17
ThromboGenics Expands Licensing Agreement with Bicycle Therapeutics 18
Bicycle Therapeutics Ltd, Key Competitors 19
Bicycle Therapeutics Ltd, Key Employees 20
Bicycle Therapeutics Ltd, Other Locations 21

List of Figures
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • The Dow Chemical Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Dow Chemical Company Merger …
  • China GrenTech Corp. Ltd.の企業概要及び財務/SWOT分析
    China GrenTech Corp. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Reed Elsevier Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reed Elsevier Group plc Mergers …
  • HandR Block, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HandR Block, Inc. Mergers and A …
  • Amyris, Inc. (AMRS):企業の財務及び戦略的SWOT分析
    Summary Amyris, Inc. (Amyris) is a renewable energy company that provides petroleum products and specialty chemicals. The company develops microbial engineering and screening technologies that modify the way microorganism’s process sugars. Amyris offers products through the segments such as cosmetic …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Arrayit Corporation (formerly Integrated Media Holdings, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Arrayit Corporation (formerly I …
  • Helix BioPharma Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Helix BioPharma Corp. Mergers a …
  • NZ Windfarms Limited (NWF):企業の財務・戦略的SWOT分析
    NZ Windfarms Limited (NWF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ProMOS Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ProMOS Technologies, Inc. Merge …
  • Menicon Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Menicon Co., Ltd. Mergers and A …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • IntriCon Corporation (IIN):企業のM&A・提携動向(医療機器分野)
    Summary IntriCon Corporation (IntriCon) is a medical device company that designs, develops and manufactures miniature and micro-miniature body worn electronic and medical devices. The company offers products such as glucose monitoring, cardiac monitoring, medical coils, plastic medical molding, ampl …
  • Coal India Limited:企業のM&A・提携・投資分析
    Coal India Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Areva SAの企業概要及び財務/SWOT分析
    Areva SA Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Areva SA annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be …
  • Giga Omni Media, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Giga Omni Media, Inc. Mergers a …
  • DualEx Energy International Inc. (DXE):企業概要、財務及び戦略的SWOT分析
    Summary DualEx Energy International Inc. (DualEx) is a petroleum and natural gas exploration and production company. The company acquires, explores, develops and produces crude oil and natural gas reserves. It carries out its business activities in Hungary and Tunisia. DualEx’s Hungarian conducts Tu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆